Company news
Cytokinetics, Incorporated news in 2019
Cytokinetics, Incorporated's news releases, calls and decks from 2019, newest first.
Cytokinetics Granted Orphan Drug Designation for Reldesemtiv for the Treatment of Amyotrophic Lateral Sclerosis
December 17, 2019
Cytokinetics Announces New Results Presented at the International Symposium on ALS/MND
December 4, 2019
Cytokinetics Announces Five Presentations at the International Symposium on ALS/MND
November 25, 2019
Cytokinetics Announces Additional Results From COSMIC-HF to be Presented at the American Heart Association Scientific Sessions 2019
November 10, 2019
Cytokinetics Announces Pricing of Public Offering of Convertible Senior Notes
November 7, 2019
Cytokinetics Announces Proposed Public Offering of Convertible Senior Notes
November 5, 2019
Cytokinetics Reports Third Quarter 2019 Financial Results
October 30, 2019
Cytokinetics to Announce Third Quarter Results on October 31, 2019
October 23, 2019
Cytokinetics Announces Second Annual Communications Fellowship Program Call for Proposals
September 24, 2019
Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23ʳᵈ Annual Scientific Meeting
September 15, 2019
Cytokinetics Announces Presentations at the 23rd Annual HFSA Scientific Meeting
September 5, 2019